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Standards of Care- 6 ABSTRACT
Methicillin Resistant Staphylococcus Aureus (MRSA) skin and soft tissue
infections are increasing in prevalence throughout the United States. The purpose of this
study was to evaluate the treatments provided to patients with abscesses and assess the
effectiveness of the treatment provided based on rate of return visits. Sister Callista Roy's
Adaptation Model was used as the theoretical framework to guide this study. A thorough
review of recent research regarding the incidence of MRSA abscesses, causative isotypes,
and treatment provided was conducted. The study consisted of a nonexperimental, quality
assurance project using a retrospective chart review design in a rural emergency
department in South Mississippi. The population consisted of all races, genders, and ages
of patients who had a discharge diagnosis of abscess. The sample included 200 medical
records of patients that were treated for an abscess and positively cultured for MRSA.
Data was systematically collected using a data collection tool designed by the
researchers. Data collected included the patients' age, race, gender, number of visits for
abscess within the past year, type of provider seen, treatment provided including
education given, follow-up within 48 hours, and number of return visits within 90 days.
Data was analyzed by a statistician with the use of descriptive statistics including fit tests,
percentiles, and frequencies using the Statistical Package for the Social Sciences (SPSS)
software program. The researchers used the data collected to determine the actual
implementation of the Centers for Disease Control and Prevention recommendations and
the effectiveness of this treatment based on the rate of return visits. The goal of this study
was to increase the mounting support for the establishment of a standard of care for the
treatment of abscesses. The results of the data were inconclusive with over 28 variations
in treatment provided. Bactrim was identified as the most prescribed antibiotic and
demonstrated the highest number of return visits. This data cannot be generalized due to
the inconsistence with follow up in an acute care setting and the broad spectrum of
treatments provided. Several variables including use of intravenous antibiotics,
intramuscular antibiotics, topical antibiotic therapies, and educational materials may have
affected the rate of return visits. The researchers were unable to identify a standard of
care due to the inconsistent treatment and rate of return. This further supports the
researchers' position that further research is needed to identify a standard of care in the
treatment of MRSA abscesses.
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CHAPTER ONE
Dimensions of the Problem

Introduction
Methicillin resistant staphylococcus aureus (MRSA) skin and soft tissue
infections are becoming increasing prevalent throughout healthcare settings. The
treatment provided varies widely between providers and practices due to the lack of a
clear consensus on treatment (Monroe, 2007). The spectrum ranges from no treatment to
intravenous antibiotics, incision and drainage, and multiple prescriptions for oral
antibiotics. MRSA is not a reportable disease in most states and the exact incidence is
unknown. Recent studies by the Centers for Disease Control and Prevention (CDC) have
examined isolates from skin and soft tissue infections and identified a new strain of
MRSA associated with community acquired infections. This strain, community acquired
methicillin resistant staphylococcus aureus (CA-MRSA), is emerging in groups without
recent hospitalizations or invasive procedures. These isolates have an increasing
resistance to antimicrobial agents, and treatment failure data is inadequate (Gorwitz et all,
2006). Based on the limited research available the CDC released recommendations for
the treatment of MRSA in skin and soft tissue infections. These recommendations
included the following: consideration of staphylococcus aureus in patients complaining of
"spider bites," specimens should be collected for culture and susceptibility testing,
incision and drainage should be performed routinely, empiric antimicrobial therapy
should be administered to patients with purulent lesions, antimicrobial therapy should be
guided by local susceptibility data with a beta-lactam agent as a first-line therapy,
intravenous antimicrobial agents should be considered for patients with severe

Standards of Care- 10 staphylococcal infections, patient education on methods to prevent spread of infection,
decolonization agents should be used only when patients have multiple recurrences of
MRS A infections or if there is an ongoing transmission of MRS A within a closelyassociated group, standard precautions should be implemented in both the inpatient and
outpatient setting, and patient's treated for skin and soft tissue infections should be
scheduled for a return visit within 48 hours for evaluation of response to therapy
(Gorwitz et all. 2006).

Problem Statement
The incidence of CA-MRSA has continually increased within the past five years.
The actual incidence is unknown but healthcare providers are reporting "virtually
epidemic proportions" of MRS A skin and soft tissue infections (Hedden, 2007). The
number of providers using CDC recommendations for the treatment of staphylococcus
aureus abscesses is not known. Research regarding the effectiveness of these
recommendations is limited. The effectiveness of the CDC recommendations has not
been appropriately evaluated. There are multiple treatment regimens being prescribed
without research to support these therapies. Ineffective treatment will lead to an increase
in antimicrobial resistance and mounting spread of MRSA within the community.
Support for the effectiveness of the CDC recommendations is needed for the
implementation of a standard of care among providers. There is a lack of research
available regarding the implementation of these recommendations.

Standards of Care- 11 Statement of Purpose
The purpose of this project is to review the treatment prescribed by providers and
evaluate the return rate for each treatment. The effectiveness of treatment provided can be
assessed by the number of return visits within a 90 day period. The review of treatments
provided will determine whether the recommendations should be implemented as a
standard of care for this increasingly prevalent disease.
Significance of the Study
In some parts of the United States, 60% to 75% of all community-acquired
isolates of 5. aureus are now methicillin-resistant (Moerelling, 2006). The most basic
recommendation is to include MRSA in the differential diagnosis of skin and soft-tissue
infections; it is the most common presentation (Sherman, 2007). Efficacy data are lacking
for decolonization with agents like nasal mupirocin and antiseptic body washes. It may be
appropriate in cases in which standard prevention measures have proven inadequate for
patients with multiple recurrences of MRSA infection and or members of a household or
other well-defined group in which transmission is ongoing (Sherman, 2007).
This study is significant to healthcare providers for all age groups. The incidence
of community acquired MRSA skin and soft tissue infections continue to rise. There is
need for education to the public. Practitioners need to ensure that proper treatment is
given to reduce the recurrence rate and decrease the spread of this infectious disease. This
study will provide support for the needed implementation of a standard of care for the
treatment of abscesses.
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Theoretical Foundation
In the proposed study, researchers will use Roy's Adaptation Model to review
provider's treatment of staphylococcus aureus abscesses, rate of return visits, and assess
the need for a standard of care. Roy theorized that ineffective responses lead to illness
and that healthcare providers treat illness by helping the patient to manage stimuli
(Perrett, 2007). Stimuli are categorized based on their effects on the human system. Focal
stimuli directly affect the system, contextual stimuli are all of the factors that contribute
to the effect of the focal stimuli, and the residual stimuli are those that have an unclear
effect on the system. Roy theorized that a person consists of six interrelated subsystems:
the regulator, cognator, physiological-physical mode, self-concept-group identity mode,
role function mode, and interdependence mode. According to Roy, the regulator is the
automatic response to stimuli through the neural, chemical, and endocrine processes, and
the cognator is the response through one of the four adaptive modes. The physiologicalphysical mode consists of the physical and chemical processes that aid adaptation in
meeting the five basic needs of oxygenation, nutrition, elimination, activity and rest, and
protection. The self-concept-group mode consists of psychological and spiritual beliefs a
person holds about oneself to meet the basic need of identity integrity. The role-function
mode exists to meet the need for social integrity through identifying the primary,
secondary, and tertiary roles one occupies. Finally, the interdependence mode centers on
the need for relational integrity that consists of the person's receptive and contributive
behaviors to relationships (Patton, 2004).
In this study, the ineffective management of stimuli can be illustrated by the
formation of the abscess in response to infection by staphylococcus aureus. The
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be the patient s demographic data. The regulator coping mechanisms will be the body's
physical, neural, chemical and endocrine response to the infection, and the cognator
coping mechanisms will be the patient's emotional response to the infection and the
provider will assist the patient with these mechanisms. The physiological-physical mode
of adaptation will be represented by the physical manifestations of the infection such as
the abscess itself and the success of the providers treatment will monitored through this
mode. The self-concept mode can be evaluated by the patient's perception of their body
image related to the abscess. The practitioner will assess how the abscess affects the role
function mode by identifying the degree of limitation in daily activities or work missed
due to the abscess, and the interdependence mode can be determined by the support
system available and impact of the infection on personal relationships. The treatment
provided including procedures and medication prescribed will be the practitioner's
management of the stimuli, and any education given regarding ways to decrease risk of
infection contribute to the patient's acquired coping mechanisms. The researcher's
review of the rate of return visits for the same infection will represent Roy's final step of
the nursing process, which evaluates if adaptive goals have been met. The resolution of
these abscesses after appropriate treatment that addresses all levels of adaptation,
represented by a standard of care, supports Roy's theory that all modes of adaptation are
interrelated. This research will contribute to the increasing evidence that the Roy
adaptation model can be used to guide current and future nursing practice.
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Standard of Care
Theoretical- Medical actions other health professionals would conduct under similar
circumstances that are used for the cure of a disease.
Operational- Treatment for abscesses as recommended by professional organizations
such as Centers for Disease Control or World Health Organization as identified on the
data tool (Appendix B, page 39). Procedures performed, medications given or prescribed
and education and instruction given by providers of a South MS emergency department
as measured by data collection tool numbers 5,6, 9, 12, 13, and 14.
Abscess
Theoretical- An enclosed collection of infective material somewhere in the body. It is the
result of the body's defensive reaction to foreign material.
Operational- An inflamed and erythematous cutaneous collection of infective material
positively cultured for MRS A as documented by the data collection tool #11.
Providers
Theoretical- Professionally trained healthcare staff.
Operational- Physicians, nurse practitioners, and physician's assistants in a South
Mississippi emergency department as measured by question eight on the data collection
tool.
Research Question
The goal of this study is to review the treatment provided to patients with
abscesses and determine whether the CDC recommendations were followed. The rate of
return visits will be used to evaluate the effectiveness of the treatment provided. The
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effectiveness of these treatments based on rate of return visits.
1. What are the current practices for treatment of abscesses presenting to the
emergency room?
2. What is the rate of return visits within a 90-day period for each treatment
provided?

Assumptions
The author assumes that the charts reviewed in the study have accurate
documentation of the diagnoses of abscess. It is also assumed that the investigator does
not misinterpret the documentation of the provider.

Limitations
The sample was not limited to age, race, or gender. The population was limited to
those who seek care in single emergency room in south Mississippi. One limitation was
the charts were reviewed from an emergency department instead of a primary care clinic;
therefore rate of return visits and previous visits may not be accurate. Education and
treatment provided may not be appropriately charted, and because information will be
gathered from archived charts all information may not be available.

Summary
The purpose of this study was to assess the current practices for treatment of
abscesses and evaluate the effectiveness of these treatments as evidenced by the rate of
return visits. The CDC recommendations are the most recent guidelines regarding the
treatment of MRSA skin and soft tissue infections but the actual implementation and
effectiveness of these guidelines has not been studied. Recent research has proven the

Standards of Care- 16 incidence ot this infectious disease is continually rising; yet evidence supporting specific
treatments has not been collected. The goal of this study is to support the need for an
established standard of care for the treatment of abscesses in the outpatient setting.
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CHAPTER TWO
Review of Literature
Introduction
An extensive search of peer reviewed journal articles was conducted to determine
the current practices for the treatment of abscesses nationwide. This review revealed an
abundance of research regarding the increasing incidence of community associated
Methicillin-Resistant Staphylococcus Aureus (MRSA). Previous research focused on the
causative isolates and incidence of these infections within specific populations. The
purpose of the proposed research is to review the actual treatment provided and assess the
effectiveness of actual practice.
Review of Literature
In a recent article in Emerging Infectious Diseases, researchers were consulted by
emergency room physicians who noticed an increase in the number of visits for skin and
soft tissue infections caused by MRSA in a Baltimore, Virginia medical center. The
researchers in this article decided to review the actual incidence of MRSA in the
emergency room, describe the isolates causing the skin and soft tissue infections (SSTIs),
and review the rate of SSTIs within the emergency room and outpatient clinics. The data
for this quantitative multi-site, retrospective study was gathered from October 1, 2000
through September 30, 2005. More than 45,000 visits were reviewed for incidence of
SSTIs and molecular typing was performed on 296 MRSA isolates from cultures
previously obtained. Patient demographic information and risk factors were obtained
from computerized medical records. Patients were grouped based on site of infection and
community-associated or healthcare-associated if the patient had been hospitalized, lived
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analysis was performed using proportions and SPSS version 12.5. Variables were
compared using x or Fisher exact tests and Student t tests. The results of this study were
statistically significant with p <0.001. Identification of isolates had a sensitivity of 84%,
specificity ol 100%, and positive predicted values of 100% and negative predicted values
of 80%. No theoretical framework was identified (Johnson et al, 2007).
The author's results of this research demonstrated both an increase in the number
of visits for SSTIs and the incidence of MRSA. Molecular typing indicated the
predominant isolate to be the USA300 clone. The researchers felt that their study helped
provide support to other recent studies illustrating an increase in the number of
community-associated MRSA infections and an increase in the incidence of USA300
clone as the causative isotype. The strengths of this study were the large number of visits
reviewed, the availability of complete medical records using the computerized medical
record system, and the consistency of findings with recent research. The limitations were
that the study was retrospective; therefore, many of the cultures were not available for
molecular typing, the population consisted of mostly male veterans of low socioeconomic
status and could not be generalized to the population as a whole, and there was no data on
treatment collected. This study will provide support for this researcher's planned study on
the need for establishing a standard of care due to the increasing numbers of MRSA
infected SSTIs. It also provides support for the recommendation of culturing all SSTIs to
appropriately treat the causative isotype (Johnson et al, 2007). The following article
reviews the susceptibility of MRSA isolates to different treatments.
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university-affiliated emergency rooms around the United States. In this multi-site,
quantitative, prospective prevalence study, researchers identified 422 patients over age 18
with an SSTI, of less than one week's duration, in the month of August of 2004.
Emergency room physicians collected the patient's demographic data, risk factors for
MRSA, and treatment provided on a standardized form. Cultures were obtained from the
largest site of infection and processed according to standard techniques at each hospital's
laboratory. Patients were contacted by telephone two to three weeks after their visit for
follow-up data collection. Descriptive statistics were used to review patient's
demographic attributes and incidence of MRSA. Bivariate analysis and multivariate
logistic regression was used to review factors associated with MRSA infection. No
theoretical framework was identified (Moran et al, 2006).
The results of this study were consistent with the previously reviewed study. In
this study the USA300 clone was present in 97% of the MRSA isolates, and 99% of the
MRSA isolates had characteristics of community-acquired MRSA. The most pertinent
statistic to the current research was that the MRSA isolate was resistant to the antibiotic
treatment prescribed in 57% of the patients, and 100% were susceptible to rifampin. The
researchers recommended the use of contact precautions for treatment of all patients with
known MRSA infections and the need to provide antibiotic treatment based on results of
cultures. They also recommended further research to review trends in antibiotic resistance
and to identify the most favorable treatment. The strengths of this study were the large
sample size, diversity of participants, large range of risk factors reviewed, and a p <
0.001. The weaknesses were that only 59% were contacted for follow up, only 42% of
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abscesses were not eligible, and two ot the researchers received funding for consulting
and lectures from Pfizer and Aventis. The current research will support the
recommendations for identification of an optimal treatment plan for this increasingly
prevalent infection. The following article provides further support for the identification of
the USA300 clone as the leading cause of community acquired MRSA (Moran et al,

2006).
Buckingham, et al. (2004) discovered that an outbreak of Methicillin-resistant
Staphylococcus aureus in a Memphis, Tennessee children's hospital was related to a
bacterial strain associated with community exposure. The authors used a quantitative
study of 289 children who were selected based on presentation during the study period
from January 2000 to June 2002. Data were collected from medical record reviews with
the Institutional Review Boards permission. The requirement for informed consent was
waived. Categorical data were analyzed using the Fisher's exact test and compared
(Buckingham, et al. 2004).
The study revealed that 52% of the isolates were community associated and 48%
of the isolates were health care associated (2004). The researchers recommended accurate
identification and treatment of methicillin resistant staphylococcus aureus along with
susceptibility testing for the most effective antibiotics. Strengths of this study include a
time frame that allowed a trend to be established. This revealed an increase in community
acquired cases as the study went on while the number of health care associated cases was
stable. Weaknesses include a limited geographical area. The researches do point out that
specific areas need to monitor for regional effectiveness in treatment This study
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pie valence of MRSA infections as well as provides data for consideration regarding
treatment. While this study is about noninvasive MRSA it is important to recognize the
increasing seriousness associated with invasive MRSA and the prevalence of increasing
cases in the community.
Klevens et. al. (2007) discovered that among the 8987 cases observed, most
invasive MRSA cases were health care related, however the prevalence of community
acquired cases was increasing. The researchers used a standardized form in the
emergency department of 9 separate sites to acquire data from personnel in the
emergency department. The study was conducted using emergency department
physicians and personnel to identify, treat, and submit data on the patients ( Klevens, et
al. 2007). These data were then analyzed and the patients' records and laboratory records
were reviewed. Descriptive statistics were used and these were analyzed using SAS
version 9.1.3. The researchers discovered 58.4% of cases met the criteria defining health
care associated infections (2007). Therapy was also reviewed and the data revealed that
concordant antibiotic therapy was used 82.4% of the time. The recommendations include
appropriated therapy for the infection and proper identification of the infection at
presentation (2007). Limitations include varied personnel collecting data and the risk of
misclassification of infection etiology. Strengths include a broad geographical sample as
well as a high population. The study serves the current project by establishing that the
MRSA infection is not stagnant but rather is worsening and is more likely to increase in
seriousness. Therapies used need to be appropriate.
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(_007) conducted a methodological comparison of prevalence of Community Associated
Methicillin Resistant Staphylococcus Aureus (CA-MRSA). This quantitative study
includes N=3022 staphylococcus aureus isolates obtained from a clinical laboratory
retrospectively within a six month period. Of these 1087 were determined to be
methicillin resistant. These specimens were wound, blood, or nasal cultures. The
researchers used the data to determine the prevalence across Manhattan and New York
City using three different methods (Furuya, et al., 2007).
The researchers performed a retrospective review of clinical and surveillance
cultures in a health care setting. The data were then separated into Methicillin
Susceptible Staphylococcus Aureus (MSSA) and MRSA by their susceptibility to
oxacillin. The researchers defined a possibility of CA-MRSA if the culture was
susceptible to Clindamycin. A prospective review of cultures was performed in an
emergency department. The screening of nares for MRSA colonization was performed
on adult patients that presented seeking treatment. In this review, the patients had to be
over eighteen years of age and consent to participate in the study. If the culture obtained
identified isolates of staphylococcus aureus growth, the Kirby-Bauer disk diffusion was
used to determine antibiotic susceptibility. The third method was performed using a
cross sectional survey of subjects in the community of northern Manhattan. The subjects
were contacted by phone from a random list and visited in the home if they consented to
participate in the survey. A culture of the participants' nares was obtained. The
difference in antibiotic resistance among the three prevalence estimates was compared by
chi-square analysis (Furuya, et al., 2007).
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and that 8.9% supported the prevalence of possible CA-MRSA. However, the
lesearcheis identified that defining susceptibility to antibiotics lead to an underestimation
ot CA-MRSA. The difference among all three methods was not statistically significant
(P=0.47). Although, the prevalence rates grossly varied from 5.5% in method one and
50% in method three (P=0.001) (Furuya, et al., 2007).
Limitations to this study were recognized by the difficulty to define CA-MRSA
across the methods included in this study. The researchers revealed in the literature that
their data did not support identifying the increasing prevalence of CA-MRSA. However,
the researchers identified antibiotic selection susceptibility to be significant in MSSA and
MRSA (P<0.0001) (Furuya, et al., 2007). Identifying prevalence factors of CA-MRSA
was difficult in research. The common value found in most research studies' pertaining
to CA-MRSA was that there is a high resistance to antibiotics.
Schneider-Linder, Delaney, Dial, Dascal, and Suissa (2007) performed a
quantitative retrospective case control study using the General Practice Research
Database (GPRD) in the United Kingdom. Using the primary care database, the
researchers were able to obtain a substantial sample to perform their research on the
receipt of antimicrobial agents and diagnosis of community acquired methicillin resistant
staphylococcus aureus (CA-MRSA). The sample eligibility consisted of the following:
no previous diagnosis of MRSA, no hospitalization in the past 2 years, and greater than 2
years follow-up recorded in the database (Schneider-Lindner, Delaney, Dial, Dascal, &
Suissa, 2007).
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ratio (OR) of the affiliation between prescribed antimicrobial drugs and subsequent
diagnosis of MRSA. Researchers then performed a separate statistical model that
contained variables for all antimicrobial drug categories. The data revealed evidence of
association between previous antimicrobial drug prescriptions and the diagnosis of CAMRSA. The OR and the 95% confidence intervals support that the risk for CA-MRSA
increased with the number of antimicrobial prescriptions" (Schneider-Lindner. Delaney,
Dial, Dascal, & Suissa, 2007).
The researchers compared the incidence of CA-MRSA in the United Kingdom to
the prevalence in the United States surveillance study and found them to be highly
consistent. Use of the GRPD enabled the researchers to increase their sample size to
provide a more valid study. Limitations to this study are identified as lack of information
in multiple areas (i.e. severity of wound infection, patient lifestyle characteristics, and
actual MRSA strain) (Schneider-Lindner, Delaney, Dial, Dascal, & Suissa, 2007). This
review of literature supports the need for the United States to make CA-MRSA a
reportable infection. Further, this study supports the need to further research to find the
appropriate use of antimicrobial drugs to limit the prevalence of CA-MRSA.
In one particular quantitative study, conducted through a microbiology laboratory
that services five hospitals and several pediatric offices in northern New England, the
dependent variable was whether a strain of Staphylococcus Aureus was healthcare
associated methicillin-resistant Staphylococcus aureus (HCA-MRSA) or CommunityAcquired methicillin-resistant Staphylococcus aureus (CA-MRSA). The independent
variable was the culture acquired from the patient. The study design was a multi-site
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microbiology lab between 1997 and 2001 (Dietrich & Mermel, 2004).
The researchers accessed 1,036 records identified by lab reports as children 0 to
18 years with MRSA. Theses reports were then identified as either health care associated
MRSA (HCA-MRSA) or community acquired MRSA (CA-MRSA) using specific
criteria. The source of data was a review of the patient's chart. A 2-sided Fischer's exact
test or Pearson's x 2 was used to calculate the results of the study. The increase in
proportion each year of MRSA was tested with at least squares linear regression (2004).
The results of the study showed that 40% of the pediatric patients studied had
community acquired MRSA. CA-MRSA cases were usually superficial and deep soft
tissue infections, and many of the isolates were susceptible to multiple classes of
antibiotics. The total number of S. aureus infections remained relatively constant over the
study period however, the proportion of the S. aureus cases attributed to MRSA steadily
increased over the five years. The researchers suggested that hospital or clinic personnel
ask family members questions targeted at identifying risk factors for MRSA acquisition
to help guide initial choice of therapy. They recommended screening cultures should be
obtained from any open wound. The efficacy and safety of the newer quinolones for
treatment of CA-MRSA in children should be investigated. The researchers indicated a
need for quick collection of specimens for culture and susceptibilities and a need for
rapid tests, which will reveal the presence or absence of virulent factors. This study was
significant to these researchers in that it indicated an increase in infections over time and
also an increase in virulence. The study indicated increasing incidence of community
acquired S. aureus (2004).

Standards of Care- 26 Because MRSA is not a reportable infection in all states makes it difficult to
determine actual prevalence in the United States. Although, the literatures supports the
need lor aggressive treatment therapy and proper antibiotic selection in order to decrease
the spread ol this infectious organism. By understanding the susceptible antibiotic
regimens to CA-MRSA. healthcare providers will be able to treat patients efficiently and
decrease the incidence of CA-MRSA. In summary the research indicates a need to
identify appropriate treatment measures for cutaneous abscesses. With staphylococcal
infections on the rise further research is needed in a variety of aspects related to the
infectious process to help providers give appropriate care.

MRSA Nasal Colonization
The next review of literature determined that MRSA colonization varies with
demographic and organism characteristics. Information was obtained regarding the
colonization of staphylococcus aureus in participants greater than one year of age and
samples collected by nasal swabs were screened for oxacillin resistance. Researchers
used the National Health and Nutrition Examination Survey (NHANES) to weight the
prevalence across the United States population (Kuehnert, et al., 2006).
There were 9929 participants examined for this quantitative study. Statistical data
revealed that colonization of staphylococcus aureus prevalence was 32.4% in these
participants. Participants shown to have the highest risk for colonization were in the six
to eleven age group (P<0.001). Using multivariate analyses, the researchers determined
that the prevalence of staphylococcus aureus was affected by age, sex, and race/ethnicity.
The researchers recognized that the differences were greater among non-Hispanic white
males and Mexican Americans. In using a second multivariate model the prevalence of
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years of age. This model did not incorporate the survey weights (Kuehnert. et al., 2006).
The researchers went further to determine antibiotic resistance in the
staphylococcus aureus and MRSA subgroup. There were 297 Methicillin Susceptible
Staphylococcal Aureus (MSSA) and 75 MRSA isolates for this study.

The data

revealed that 77.1% were susceptible to all non-B-lactam agents tested, yet only 12.5%
were susceptible to penicillin (Kuehnert, et al., 2006).
Limitations of this study were with the measurement of prevalence in a crosssectional design and participants were not serially cultured. Second, a cohort effect was
possible among age groups in different demographic regions. Third, previous
antimicrobial exposure, occupation, or other underlying conditions were not analyzed to
determine the multiple effects on colonization. Fourth, the data obtained were collected
in 2001-2002; therefore, colonization rates may have changed. Finally, using small
sample sizes, all MRSA isolates may have not been detected. (Kuehnert, et al., 2006)
There are however strengths to this study. Researchers did determine that there were
antibiotic resistances in MRSA and that rapid identification of MRSA could lead to more
aggressive treatment and decolonization and spread of this infectious organism
(Kuehnert, et al., 2006). With increasing incidence of skin and soft tissue infections
presenting to emergency departments and other outpatient settings, the treatment
provided for these patients is not consistent. This study is relevant to support continuing
research on the spread and aggressive treatment therapy for patients.
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Theoretical Framework
The following study by Tsai (2005) used the Roy Adaptation Model as a theoretic
framework, as will be done in this researcher s study. This was a quantitative study that
used information gathered throughout the continental USA. The independent variable
was the theory of chronic pain and the dependent variable was financial hardship.
The design type was a secondary data analysis strategy with study variables
developed from the original data sets of a previous study and based on a theory of chronic
pain derived from the Roy Adaptation Model. The sample size was 235. Probability
sampling was used, with over sampling. People in the group were selected if they were
aged 65 and older. Only the 1998 data were used for this study and only people who had
arthritis and were 65 years or older (Tsai, 2005).
Data were obtained from the study of Ageing, Status, and Sense of Control
carried out in 1998 in the United States of America. Variables were constructed from the
original questionnaires of this study. The theory was tested with 235 elders with arthritis
using a secondary data analysis strategy. Researchers took the original data and identified
scores on financial hardship and used these to attempt to identify if financial hardship
affected pain and distress (2005).
This sample was tested with univariate analysis. Chi-square and goodness-of-fit
indices were calculated. The researchers found that elders who experienced pain more
often were more likely to be disabled and experienced more financial difficulties, though
financial problems only affected distress to a small degree. Social support, financial
hardship and age most often caused distress that led to depression. Tsai (2005) found this
study significant in helping identify use of a theory in research.
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between chronic pain, distress and depression. The researcher of this study identified the
need to narrow the study to persons with only one type of arthritis or possibly broaden the
study to look at pain, distress and depression people without arthritis, since many arthritis
sufferers have difficult financial situations.
A strength of the study was that the researchers were able to use a broad sample.
One limitation was that this was a secondary data analysis and only variables in the
original study were available, which limited the possibility of looking at other issues that
might have been of interest to these researchers.

Summary
Researchers have identified MRSA SSTIs as an increasingly prominent problem
throughout the United States. The review of literature reveals a focus on the causative
isotypes rather than the treatment provided. The researchers did discuss the results of the
antimicrobial sensitivity of the SSTIs cultured but did not review the actual treatment
provided for these abscesses. The authors of several articles had treatment
recommendations consistent with the recommendations of the CDC. Further research
regarding the effectiveness of treatment provided and the increase in antimicrobial
resistance was recommended by the authors of all literature reviewed. Examination of the
recent research reveals a lack of evidence supporting any specific treatment plan or
recommendations for decreasing the incidence of MRSA in the community.

Standards of Care- 30 -

CHAPTER THREE
Design and Methodology

Introduction
This study consists of a nonexperimental, quality assurance project using a
retrospective chart review to examine the treatment provided for patients' with abscesses
in the outpatient setting. Data will be obtained from archived charts at a Southern
Mississippi emergency department. This facility provides urgent care to both an urban
city and the surrounding rural areas. The population consists of middle and lower
socioeconomic groups of all races.

Population and Sample
The proposed population encompasses patients of all genders, races, and ages,
who present to a Southern Mississippi emergency department with a diagnosis of abscess.
The sample includes selected medical records of all patients seen in the emergency
department between the months of January 2007 and March 2007 with a discharge
diagnosis of abscess.

Protection of Human Subjects
Prior to collection of data, approval from the Human Subjects Institutional
Review Board (1RB) at Mississippi University for Women and the medical facility where
data collection will occur will be obtained. After approval from the IRB, a written letter
of consent will be obtained from the administration of the South Mississippi medical
center. The data collection tool will not contain any identifying information such as
name, birth date, medical record number, or social security number. The collected data
will be kept in a locked file accessible only to the researchers.
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Procedure for Data Collection
Data will be collected from the first 200 archived charts dated between January
2007 and March 2007 with a discharge diagnosis of abscess and a culture positive for
Methicillin Resistant Staph Aureus (MRSA). By using the Emergency Department's Epoint system a query for diagnosis of cutaneous abscess will be obtained. The E-point
system is a charging system which requires diagnosis entry. A log of patient's medical
record numbers will be kept to avoid repetitive data collection on the same patient and to
allow researchers to access information on return visits. In addition, culture and
sensitivity reports will be obtained to analyze organism of infection and susceptibility to
prescribed antibiotic therapy. The facility AS400 system will be used to obtain return
visits within 90 days of initial visit. The AS400 system contains all patient encounters at
this facility.
The data collection tool (appendix B) will be used to systematically collect
information without the use of identifying factors other than the medical record number.
The data collection tool includes demographic data and treatment provided. Data will be
collected over the period of one month by all researchers.

Instrumentation
A chart review tool was designed by the researcher to assess the actual treatment
provided to patient's presenting to the emergency room with an abscess (Appendix B).
The demographic data of age, gender, and race of each client was included on the tool.
The type of provider who prescribed or administered the treatment is also included on the
chart review tool. Lastly, the incidence of return visits within 90 days after treatment and
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face validity as evaluated by the research committee.

Treatment of Data
The Statistical Package for the Social Sciences (SPSS) software program will be
used to analyze the data. Analysis of the data will include descriptive statistics and
percentages. AT- test between providers was completed. An ANOVA between
treatment regimens was done. The names of patients and the emergency room where data
will be collected will not be published. All data collected will be stored in a locked, fire
proof safe and kept for five years after completion of the study, then shredded.

Summary
This study will consist of a retrospective chart review to assess the treatment
provided for abscesses in the outpatient setting. A chart review tool created by the
researcher will be used to collect the data without identifying information being
collected. Statistical analysis of the data will be performed using SPSS software.
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Chapter Four
Data Analysis

Introduction
The purpose of this project was to review the treatment prescribed by providers
for cutaneous staphylococcal infections and evaluate the return rate for each treatment. In
this chapter the results of the data collected will be discussed.

Profile of Study Participants
Participants in this study were visitors to the emergency department of a south
Mississippi hospital. Patients were of various ages, races, and socio economic groups.
The age range of patients seen with cutaneous lesions was birth to age 70 with the
greatest number of patients seen being in the 21 to 30 age group.

Age of Patients
Category
• 0 - 10

4.0%

5.0%

• 11-20

•
•
•
•
•

21-30
31-40
41-50
51-60
61 - 70
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consisting of Caucasians with 56.5%, African Americans 39.0%, and Hispanics 4.5%.

Racial Make-up of Patients
Category

4.5%

I

I African American

Q Caucasian
• Hispanic

The distribution of gender of patients was uneven with a significantly larger group
of females than males.
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Gender of Patients
Category
• Female
El Male

Statistical Results
First the researchers reviewed the current practices for treating abscesses
presenting to the emergency department. The following table shows the trequency and
percent of each type of oral antibiotic prescribed.
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Frequency and Percentage of Antibiotics Prescribed
Oral Antibiotic

Frequency

Percent

Bactrim

118

59%

Bactrim and Clindamycin

31

15.5%

Bactrim and Doxycyline

2

1%

Bactrim and Rifampin

20

10%

Bactrim and Other

1

0.5%

Clindamycin

16

8%

Clindamycin and
Doxycyline

1

0.5%

Clindamycin and Other

2

1%

Doxycyline

2

1%

No Antibiotics

2

1%

Other Antibiotics

5

2.5%
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Oral Antibiotic Prescribed
Category
CD Bactrim

CD Bactrim, Clindamycin
H Bactrim, Doxycyline
• Bactrim, Other
CD Bactrim, Rifampin
• Clindamycin

£i Clindamycin, Doxycyline
Q Clindamycin, Other
CD Doxycyline
• Nothing
I I other

Using a chi-square goodness of fit test at the 1% significance level the data do
provide sufficient evidence to conclude that there is a difference in the distribution of
combination oral antibiotic prescriptions. The evidence against there being no difference
is very strong with a p-value of less than 0.0001.
Ninety-nine and one half percent of the patients had an incision and drainage and
100% of the patients had a culture and sensitivity test performed. Fifty one and one half
percent of the patients did not receive educational materials at their discharge while
48.50% of the patients did receive them.
The second question reviewed the rate of return visits for each treatment
provided. At the 1 % significance level the data do provide sufficient evidence to
conclude that there is a difference in the distribution of the number of return visits within
90 days. The evidence against the number of return visits being evenly distributed was
highly significant with a p-value of 0.0001.
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Number of Return Visits within 90 days
Category

0.5%

•0
•1
• 2

•3

One hundred percent of those who were seen in the emergency department and
received no treatment did not have a return visit. Of the patients who were prescribed
Doxycyline 100% never returned to the emergency room. Of those patients prescribed
Bactrim, approximately 79% did not return to the emergency room and of those given
Clindamycin 68% also, never returned. Sixty percent of those that were given an alternate
type of oral antibiotic did not return.
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Returning Visits Within 90 Days
140-

Bactrim

Clindamycin

Doxycyline

Nothing

Other

At the 1% significance level the data do provide sufficient evidence to conclude
that there is a difference in the distribution of number of days returning based on what
type of oral antibiotic is prescribed. The evidence against the number of days returning is
evenly distributed and is highly significant with a p-value of < 0.0001.
The following table shows the frequency and percent of those that are given an
intramuscular antibiotic and the number of returning visits within 90 days. Sixty-one and
one half percent of those that received Clindamycin as an intramuscular antibiotic had
zero returning visits within 90 days. 100% of patients that received another type of
intramuscular antibiotic did not return.

Rate of Return for Patients Receiving Intramuscular Clindamycin
Clindamycin
0 Visits
1 Visit
2 Visits

Frequency
8
4
1

Percent
61.54%
30.77%
7.69%
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The following table shows the frequency and percent of the patients that were
given an intravenous antibiotic and the number of returning visits within 90 days. 100%
of those given Clindamycin intravenously did not return within 90 days. Of the patients
that were not given any intravenous antibiotics 77.72% did not return within 90 days.

Rate of Return for Patients Receiving Intravenous Antibiotics
Clindamycin
0 Visits

Frequency
2

Percent
100%

Other Intravenous
Antibiotics
0 Visits

Frequency

Percent

4

80%

1 Visit

1

20%

No Intravenous Antibiotics
0 Visits

Frequency
150

Percent
77.72%

1 Visit

33

17.10%

2 Visits

9

4.66%

3 Visits

1

0.52%

The distribution of return visits based on intravenous antibiotic prescribed is
unequal. One can conclude that at the 1% significance level the data do provide sufficient
evidence to conclude that the distribution of return visits were different among patients
that received intravenous antibiotics.
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Chapter Five
Summary and Conclusions

The Outcomes
The purpose ol this project was to review the treatment prescribed by providers
for cutaneous staphylococcal infections and evaluate the return rate for each antibiotic
treatment. The conceptual framework was Roy's Adaptation Theory. The guiding
research questions for this study were:
(1) What are the current practices for treatment of abscesses presenting to the emergency
room? (2) What is the rate of return visits within a 90-day period for each treatment
provided?
The sample consisted of 200 randomly selected medical records from the
emergency department of a south Mississippi hospital. Data were collected using a data
collection tool developed by the researchers. Data were analyzed using percentages and
chi square goodness of fit tests.

Limitations
This study was limited because some participants may have followed up with a
private physician or in the emergency department of another hospital if their infection
persisted or returned. The study was also limited by whether the treatment regimen was
accurately recorded by the provider and or staff. Additionally, the study was limited by
the inability to assess the severity of the patients' infection using the researcher
developed tool. Thus researchers could not identify treatment based on level of severity.
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Discussion and Conclusions
The data indicated that Bactrim was the most prescribed medication, either alone
or in combination, for lesions that were identified as Methcillin Resistant Staphylococcus
Aureus. There were more return rates for Bactrim than for other antibiotics; however,
Bactrim was prescribed in a much higher proportion allowing for increased possibility of
return visits. The Center tor Disease Control has established that Bactrim is the preferred
antibiotic as part of a standard of care for treatment of MRSA. (Gorwitz R„ Jernigan D.,
Powers J., Jernigan J. et.al., 2006). Clindamyacin was also used alone and in
combination with Bactrim with low return rates in 90 days. This would indicate the use of
Clindamyacin as a possible element in a standard of care for MRSA. In this sample it was
used less than Bactrim and thus data is inconclusive and would require further study.
In a study conducted by Moran, et. al. 2006, the researchers recommended the use
of contact precautions for treatment of all patients with known MRSA infections and the
need to provide antibiotic treatment based on results of cultures. They also recommended
further research to review trends in antibiotic resistance and to identify the most
favorable treatment.
The researchers in this study identified that there were approximately 28 different
treatments or combinations of treatments used by providers on the 200 patients in this
study. While oral antibiotics were reviewed in this paper, intravenous antibiotics were
also used, as well as various combinations of oral and intravenous treatments.
Combinations of oral medications with topical treatments were provided in some cases.
There did not seem to be a set standard of care followed by providers in this study as can
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the researcheis position that a standard of care should he instituted for treatment of
MRSA.

Implications for Nursing
Controlling the spread of MRSA requires providers to prescribe a standard of care
for patients with MRSA. Equally important is the need to educate the patient about how
MRSA is spread, how to decrease the spread in the home through proper hand washing,
wound care and cleaning (Sherman, 2007). Nurses must provide the patient with
information and education on prevention and treatment duration which will depend on
severity of illness and clinical response. Also important for the nurse practitioner is to
recognize treatments which are most effective and use these to help guide patient care
(Hedden, 2007). According to Roy's adaptation theory the physiological-physical mode
consists of the physical and chemical processes that aid adaptation in meeting the five
basic needs of oxygenation, nutrition, elimination, activity and rest, and protection. This
is the mode that the practitioner will be able to address with effective treatments (Patton,
2004).
Nursing staff as well as providers must remember frequent hand washing. They
must also be sure to sanitize equipment such as blood pressure cuffs, tables and other
items that may come in contact with the infected patient so that the infection will not be
spread to the client who next enters the exam area (Buckingham, et al. 2004).

Future Research
More research is needed to identify more specific treatment plans and the
recurrence of MRSA among family members and or community members. The
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follow up visits can be more accurately assessed. Using this study as a pilot study, a
larger sample covering a greater geographical region could reveal more significant data.
A research study using a specific treatment regimen, such as use of Bactrim, Bactroban or
Altabax and Hibiclens along with patient education could be compared to other treatment
regimens. This would help identify if a full treatment regimen decreased recurrence of
MRSA and thus help develop a definitive standard of care for treatment of MRSA.

Conclusion
This research supported practitioners' knowledge that use of Bactrim when
treating MRSA is appropriate. The study also indicated that studying results of MRSA
treatment in the emergency department did not reveal enough data related to return visits
possibly due to the limitations of the study. If repeating this study the researchers would
use multiple clinic settings to collect data. The tool would also be reformatted to allow
for identifying the severity of the wound which would help increase understanding of
treatment choices by the provider.
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MISSISSIPPI UNIVERSITY FOR WOMEN
INSTITUTIONAL REVIEW BOARD
IDENTIFICATION OF INVESTIGATORS AND BRIEF DESCRIPTION OF
INVESTIGATORS AND BRIEF DESCRIPTION OF
PROPOSED RESEARCH REVIEW
TITLE OF STUDY:

Providers Use of Standards of Care for Methicillin Resistant Staphylococcus
Aureus
PRINCIPAL
INVESTIGATOR: Victoria Ashley Ford. Suzanne Cox. Lisa Gatwood. Jeff Moffett
(Signature)
DEPARTMENT School of Graduate Nursing
Date) April 14.2008
RESEARCH ADVISOR: Mrs. Amelia Higginbottom, RN. MSN, CFNP
(Signature)
Instructions: In the space below (use additional sheets where necessary):
1. Briefly describe the purpose and nature of the present research proposal. State what, if
any, benefit is to be gained by the subject(s) or what information is to be added to the
general body of knowledge as a result of this research.
2. List all procedures to be used on human subjects with a description of those you
consider beyond already established and accepted techniques.
3. Describe the necessary safeguards to be applied to protect the subject.
4. State whether or not you consider the subject to be "at risk." If you consider the subject
to be "at risk", in what respect do the potential benefits to the subject or contributions to
the general body of knowledge outweigh the risks?
5. If you consider the subject to be "at risk," state exactly what you tell him in lay
language to obtain informed consent relative to each procedure wherein he is "at risk.
This must be a form that is given or read to the subject particularly for this purpose. II
subjects are children what will be told to parent or legal guardian ?
6. State from whom documentation of informed consent will be obtained.
7. Attach copies of all questionnaires to be used.
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1.) The purpose of this project is to review the treatment prescribed bv providers and
evaluate the return rate for each treatment. The number of return visits can assess
the effectiveness of treatment provided within a ninetv-dav period. The review of
treatments provided will determine whether the recommendations should be
implemented as a standard of care for this increasingly prevalent disease.
2.) This research will consist of a retrospective chart review and no procedures will
be used on human subjects.
3.) After approval from the IRB. a written letter of consent will be obtained from the
administration of the South Mississippi medical center. The data collection tool
will not contain any identifying information such as name, birth date, medical
record number, or social security number. The collected data will be kept in a
locked file accessible only to the researchers.
4.) The subject will not be "at risk" because only a retrospective chart review will be
performed and all data will be protected.
5.) The subject is not considered "at risk".
6.) Informed consent will be obtained from the administration of a South Mississippi
medical center.
7.) No questionnaires will be used in this research.
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EVALUATION FORM FOR
INSTITUTIONAL REVIEW BOARD
Date Submitted to Committee: April 8,2008
Title of Investigation: Providers' Use of Standards of Care for Methicillin Resistant
Staphylococcus Aureus
Principal Investigator: Victoria Ashley Ford. Suzanne Cox. Lisa Gatwood. Jeff Moffett
Funding Agency: No additional funding will be obtained.
Funding Agency Grant Number: (NIH, BEIT, when applicable): Not applicable.
Anticipated number of human subjects to be studied (when applicable): 200
Projected duration of Investigation: Approximately one month to collect data.
Age range of human subjects: All ages will be included in chart review data collection.
Any mental or physical impairment present in the subjects:
Subject's mental or physical impairments will not be known to investigators reviewing
charts.
Criteria for subject selection:
Any patient who was seen in a South Mississippi Emergency Department with a
discharge diagnosis of abscess.
Potential for beneficial effect to human subject arising from investigation: This study will
provide support for the needed implementation of a standard of care for the treatment ol
abscesses.
Potential adverse effects (psychological, behavioral and physiological ) aiising from
investigation: No potential for adverse effects due to use o l retrospective chart ie\ icw.
Potential or established side effects of drugs used in investigation.
No drugs will be used in the investigation.
Brief justification of research where immediate benefit to specific human subject is
absent or unknown:
No research will be performed that will effect the human subject.
For On-Going Investigations Only. Number of subjects studied.
Not applicable.
Documented adverse psychological, behavioral, physiological and pharn
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Precautions used to detect, prevent, minimize or reverse adverse side effects:
Change in methods or procedures (when applicable):
Change in intent, direction or scope of research (when applicable):
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FORM C
SAMPLE OF INFORMED CONSENT
INSTITUTIONAL REVIEW BOARD :

DearXXXXXXXXXXX.
We are graduate students in the nurse practitioner program at Mississippi
University for Women. We are conducting a research study regarding the treatment of
methicillin resistant staphylococcus aureus cutaneous abscesses and their return visits.
The results of this study will contribute to the recognition of a need for a standard of care
in this increasingly prominent diagnosis. This study has been approved by the Mississippi
University for Women's Committee on use of Human Subjects in Experimentation.
Your facility's participation would involve allowing us to review medical records
of patient's that present to your emergency department with a diagnosis of abscess. All
information obtained will be kept confidential and used only for the purpose of this study.
Neither names, nor any identifying data will be used, and the name of your facility will
not be published.
Your participation in this study is strictly voluntary, and your facility may
withdraw at any time prior to data analysis. Information will be obtained in the form ot a
retrospective chart review. After the research study is complete, we will provide you with
results of the data collected.
If you have any questions concerning this study please contact Ashley Ford at
(601) 264-6286, 19 Hunters Way, Purvis, MS 39475; Suzanne Cox (601) 736-0168, 1030
Prospres Ridge Road, Columbia, MS 39429; Lisa Gatwood (601) 270-2611, 20 Jubilee
Point, Hattiesburg, MS 39402; Jeff Moffett (601) 580-4657, 34 Kinderley Drive, Laurel,
MS 39440, or the chair of our research, Mrs. Amelia Higginbottom, RN, MSN, CFNP, at
(662) 329-7321. Thank you for willingness to consider this request.
Sincerely,
Ashley Ford
Suzanne Cox
Lisa Gatwood
Jeff Moffett
************************

I have read this letter of consent and have been given the opportunity to a s k questions,
give my consent to participate in the above study. In addition, the leseaicheis w I
that confidentiality is maintained and HIPPA regulations are tollowe

Name (please print)

Signature

Date
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GUIDELINES FOR THE PROTECTION OF HUMAN RIGHTS
INSTITUTIONAL REVIEW BOARD
Review Form D
If "no" checked, please explain in writing and attach.
1. Right to Privacy
YES / NO
1.1 Obtained free and informed voluntary written consent. YES
1.2 Provide for anonymity
YES
1.3 Information obtained held in confidence
YES
1.4 When a reasonable possibility exists that others may obtain access to information,
plans for protecting the confidentiality are explained to the subject. YES
2. Right to Self-determination
2.1 Voluntary consent obtained without overt or covert coercion. YES—
2.2 Deception of subject or concealment of purpose avoided YES
2.3 When concealment is necessary, it is communicated to the subject and a contract is
made to inform the subject as the design permits.
N/A
2.4 Explanations are not ambiguous and the terminology used is appropriate to the
subjects level of understanding.
YES
2.5 Subject free to withdraw consent at any point and informed of such. YES
2.6 Obtained third party written consent if necessary.
YES
3. Rights of Minors and Legally Incompetent Person
3.1 If a minor, informed written consent from parents required and obtained. N/A
3.2 If legally incompetent, informed written consent from legal guardian required and
obtained.
N/A
3.3 Supplemental written consent obtained from minor when minor has capacity to
comprehend implications of study.
N/A
4. Right of Conservation of Personal Resources
4.1 Time, freedom from constraint, and personal resources are not abused. T ES
4.2 Subject is informed about the nature, extent, and possible consequences ot study A ES
5. Right to Freedom from Arbitrary Hurt
5.1 Subject protected from arbitrary mental and/or physical suffering as a result ot study.
YES
6. Right to Freedom from Intrinsic Risk of Injury
6.1 Subject has full information about proposed investigation it there is a risk ot
emotional and/or physical injury.
YES
7. Additional Safeguards
7-1 Deviation from any of the above principles.
7.2 Evidence demonstrated that appropriate expert advice has been iecei\ed that it is
acceptable to deviate.
—
7.3 The researcher has demonstrated that research assistants have been, or wt
in the ethics involved in carrying out the research design.

,

.
,
e raine

VES

Vice President for Academic Affairs Date
TT .
f.,; .;„M
REFERENCE: ANA Ethical Guidelines APA Ethical Principles University of Michig ,
Guidelines for the Protection of Human Rights Univeisity ot In lana, ui e I
Protection of Human Rights
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Wesley Medical Center
Institutional Review Board Submission Form

Date: April 2008
Title of project: Providers' Use of Standard of Care for Staphylococcus Aureus Abscess
Principal Investigator: Victoria Ashley Ford, Suzanne Cox. Lisa Gatwood. Jeff Moffett
Phone: 601-264-6286
Name of contact person: Lisa Gatwood

Phone: 601-270-2611

E-mail: LANDMGAT@aol.com
Sponsor: Amelia Hiuginbottom MSN, APRN. BC. ANP/PNP

The PI must submit material for consideration by the IRB at least two (2) weeks prior to a
scheduled IRB meeting in order to process the material for the individual members of the
IRB Committee.

The PI must submit the following:
A. The full protocol addressing the following, if applicable to the study:
The title of the study
The purpose of the study
*
The sponsor of the study
'r
The results of the previously related research
*
The subject selection criteria
>
The subject exclusion criteria
>
The justification for use of any special/vulnerable subject populations
^

'r
r>
^
>
^

The
The
The
The
The
The
The
The
The
The

study design
description of the procedures to be performed
provisions for managing adverse reactions
circumstances surrounding the consent procedure
procedure for documentation of informed consent
compensation to subjects for their participation
compensation for injured research subjects, if any
provisions for protection of the subject s privacy
extra costs to subjects for their participation in the study
extra costs to third party payers because ot the subjects participat

B. The informed consent form specific to Wesley Medical Center and the PI
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D.
E.
F.
G.
H.

The HIPAA authorization form specific to Wesley Medical Center.
All questionnaires that will be used with participants.
All recruitment materials and a description of recruitment processes.
The Investigator's Brochure (if available).
Grant applications if applicable.
HHS-approved sample informed consent document and protocol for HHSsupported multi-center trials.
I. Any other relevant materials, including all advertisements, including public
service announcements for their ethical propriety.
J. Pis may submit protocols to the 1RB only after the PI has received approval in
writing from any hospital departments that will participate in the study, such as
nursing, pathology, pharmacy, laboratory, or infection control.
K.. Send 18 copies of the above information to the IRB Coordinator listed below.
L. Te protocol, after IRB approval, will be placed in the Wesley Medical Center IRB
website.

Submit information with this form to:
Roger Flowers, IRB Coordinator
Pastoral Services
Box 16509
Hattiesburg, MS 39404
601-459-1388
roger.tlowers@wesley.com
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Research Tool
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Data Collection Tool
1. Age:

•
a
•
•
a
•
•

0-10 years old (1)
11 -20 years old (2)
21-30 years old (3)
31-40 years old (4)
41-50 years old (5)
51 60 years old (6)
61-70 years old (7)

9. Oral antibiotic prescribed:
• None (1)
• Bactrim (2)
• Clindamycin (3)
• Rifampin (4)
• Doxycyline (5)
• Other (6)

2. Race:
•
•
•
•

Caucasian
African- American
Hispanic
Other

10. Parenteral antibiotic given: IM IV
• Clindamycin (1)
• Gentamycin (2)
• Other (3)

•
•

Male (1)
Female (2)

11. Bactroban prescribed:
• Yes(l)
• No (2)

3. Gender:

4. Type of Provider:
• MD (1)
• NP (2)
• PA (3)

5. Number of visits within previous year for
abscess:
• 0
•

1

•
•

2
3

6. Number of return visits within 90 days:
• 0
•

1

•
•

2
3

7. Incision and Drainage performed:
• Yes(l)
• No (2)
8. Culture and sensitivity performed:
• Yes (1)
• No (2)

••
••
••

12. Hibiclens prescribed:
• Yes (1)
• No (2)
13. Education materials given at time of
discharge.
• Yes (1)
• No (2)

14. Did patient return for recheck within
48 hours:
• Yes (1)
• No (2)

Standards of Care- 58 Subject #_
Data Collection Tool

1. Age:

•
•
•
a
•
•
a

0-10 years old (1)
11-20 years old (2)
21-30 years old (3)
31-40 years old (4)
41-50 years old (5)
51-60 years old (6)
61-70 years old (7)

9. Oral antibiotic prescribed:

•
•
•
•
•
•

None (1)
Bactrim (2)
Clindamycin (3)
Rifampin (4)
Doxycyline (5)
Other (6)

2. Race:

• Caucasian
• African- American
• Hispanic
• Other
3. Gender:

a
•

Male (1)
Female (2)

4. Type of Provider:

•

MD (1)
NP (2)
PA (3)

a
a

5. Number of visits within previous year for
abscess:
• 0
•

1

• 2
•

3

. Number of return visits within 90 days:
• 0
•

1

•
•

2
3

Incision and Drainage performed:

•
•

Yes (1)
No (2)

Culture and sensitivity performed:
• Yes(l)
• No (2)

10. Parenteral antibiotic given: IM

• Clindamycin (1)
• Gentamycin (2)
• Other (3)

IV

• O

••
••

11. Bactroban prescribed.

•
•

Yes (1)
No (2)

12. Hibiclens prescribed:

•
•

Yes(l)
No (2)

13. Education materials given at time of
discharge:

•
•

Yes (1)
No (2)

14. Did patient return for recheck within
48 hours.

•
•

Yes(l)
No (2)

Appendix C
Letter of Consent
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.

We are graduate students in the nurse practitioner program at Mississippi
University for Women. We are conducting a research study regarding the treatment of
methicillin resistant staphylococcus aureus cutaneous abscesses and their return visits.
The results ot this study will contribute to the recognition of a need for a standard of care
in this increasingly prominent diagnosis. This study has been approved by the Mississippi
University for Women's Committee on use of Human Subjects in Experimentation.
Your tacility's participation would involve allowing us to review medical records
of patient's that present to your emergency department with a diagnosis of abscess. All
information obtained will be kept confidential and used only for the purpose of this study.
Neither names, nor any identifying data will be used, and the name of your facility will
not be published.
Your participation in this study is strictly voluntary, and your facility may
withdraw at any time prior to data analysis. Information will be obtained in the form of a
retrospective chart review. After the research study is complete, we will provide you with
results of the data collected.
If you have any questions concerning this study please contact Ashley Ford at
(601) 264-6286, 19 Hunters Way, Purvis, MS 39475; Suzanne Cox (601) 736-0168, 1030
Prospres Ridge Road, Columbia, MS 39429; Lisa Gatwood (601) 270-2611, 20 Jubilee
Point. Hattiesburg, MS 39402; Jeff Moffett (601) 580-4657, 34 Kinderley Drive, Laurel,
MS 39440, or the chair of our research, Mrs. Amelia Higginbottom, RN, MSN, CFNP, at
(662) 329-7321. Thank you for willingness to consider this request.
Sincerely,
Ashley Ford
Suzanne Cox
Lisa Gatwood
Jeff Moffett
************************

I have read this letter of consent and have been given the opportunity to ask questions. 1
give my consent to participate in the above study. In addition, the researchers will assuie
that confidentiality is maintained and HIPPA regulations are followed.

Name (please print)

Signature

